SCHEMBL6236137

SCHEMBL6236137

Pc1ccc(I)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13625949 0.90 METAP2 (0.34) —
SCHEMBL10597056 0.78 HDAC8 (0.50) —
SCHEMBL67142 0.78 — —
SCHEMBL18923191 0.70 NOS1 (0.35) —
SCHEMBL48310 0.69 — —
SCHEMBL66792 0.67 METAP2 (0.42) —
SCHEMBL75931 0.67 METAP2 (0.42) —
SCHEMBL2069523 0.67 METAP2 (0.42) —
SCHEMBL9576929 0.67 HDAC8 (0.41) —
SCHEMBL6522404 0.67 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005010028-A1 ALPHA-AMINO ACID BENZOTHIAZOLYLTHIO ESTER AS INTERMEDIATES FOR MANUFACTURE OF ACE INHIBITORS AND PROCESS FOR PREPARATION THEREOF LUPIN LIMITED (IN) 2005-02-03 — — WO claimed
CN-115286661-A Boron-containing bis-hexatomic spiro derivative and application thereof 棓诺(苏州)新材料有限公司 2022-11-04 — — CN disclosed
US-11072635-B2 Macrocyclic broad spectrum antibiotics RQX PHARMACEUTICALS, INC. (US) 2021-07-27 — — US disclosed
US-20200239519-A1 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS RQX PHARMACEUTICALS, INC. 2020-07-30 — — US disclosed
US-10550089-B2 Inhibitors of protease-activated receptor-2 HEPTARES THERAPEUTICS LIMITED (GB) 2020-02-04 — — US disclosed
US-20190144394-A1 INHIBITORS OF PROTEASE-ACTIVATED RECEPTOR-2 HEPTARES THERAPEUTICS LIMITED (GB) 2019-05-16 — — US disclosed
US-10221170-B2 Difluoropyrrolidines as orexin receptor modulators EOLAS THERAPEUTICS, INC. (US) 2019-03-05 — — US disclosed
US-20180099954-A1 NOVEL KAPPA OPIOID LIGANDS SCRIPPS RESEARCH INST (US) 2018-04-12 — — US disclosed
US-20170226103-A1 DIFLUOROPYRROLIDINES AS OREXIN RECEPTOR MODULATORS NIUVERA BIO, INC. 2017-08-10 — — US disclosed
US-9682966-B2 Kappa opioid ligands THE SCRIPPS RESEARCH INSTITUTE (US) 2017-06-20 — — US disclosed
US-20170050941-A1 NOVEL MODULATORS OF SPHINGOSINE PHOSPHATE RECEPTORS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2017-02-23 — — US disclosed
US-7956206-B2 Metal complex CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) 2011-06-07 — — US disclosed
US-20080088224-A1 Metal Complex CDT OXFORD LIMITED (GB) 2008-04-17 — — US disclosed
WO-2005010028-A1 ALPHA-AMINO ACID BENZOTHIAZOLYLTHIO ESTER AS INTERMEDIATES FOR MANUFACTURE OF ACE INHIBITORS AND PROCESS FOR PREPARATION THEREOF LUPIN LIMITED (IN) 2005-02-03 — — WO disclosed
US-6563005-B1 Reacting aryl compound with phosphine in presence of Group VIII metal catalyst CYTEC TECHNOLOGY CORP. 2003-05-13 — — US disclosed
Send feedback